
Bavarian Nordic CEO Paul Chaplin Steps Down After 12 Years
Paul Chaplin, the CEO of Bavarian Nordic, is stepping down from his position after 12 years at the helm of the Danish biotechnology company.
2 stories found

Paul Chaplin, the CEO of Bavarian Nordic, is stepping down from his position after 12 years at the helm of the Danish biotechnology company.
The EU is backing research into a new type of vaccine against infectious influenza. The project involves Statens Serum Institut and Bavarian Nordic, operating under the umbrella of the Novo Nordisk Foundation.